Treating Complex Cases of Arterial Disease: How to Reduce Risk for CV Events?
- Demonstrate improved performance associated with
- Tailoring antithrombotic therapy for coronary artery disease (CAD) in patients with comorbidities to reduce the risk for CV disease
- Using appropriate antithrombotic therapy in patients with peripheral artery disease (PAD) to reduce the risk for arterial and limb events
- Using effective, patient-centered strategies to improve management of CAD and PAD
Associate Professor of Medicine
Director of Vascular Research
University of Colorado School of Medicine
Executive Director; CPC Clinical Research
Kelley Robert Branch, MD, MS
University of Washington
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Developed through a collaboration between the University of Chicago Medicine and Medscape Education.
Other Healthcare Professions Credit